Vimarsana
Biggest News Aggregation in the World

Page 21 - Multiple Sclerosis Centers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Sclerosis Centers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Sclerosis Centers Today - Breaking & Trending Today

New Consensus Guideline on Clinical MRI Use in MS - Vimarsana News

New Consensus Guideline on Clinical MRI Use in MS

A new consensus guideline, created collaboratively between three international organizations, has been designed to boost much-needed protocol adherence during routine clinical use of MRI.

DMTs Often Switched During COVID, but Was It Necessary? - Vimarsana News

DMTs Often Switched During COVID, but Was It Necessary?

Many US clinicians who treat for multiple sclerosis adjusted drug regimens during the pandemic's early months to lower risk for COVID-19 infection -- but they didn't need to, experts say.

New MS Drug Does Not Appear to Increase COVID Severity - Vimarsana News

New MS Drug Does Not Appear to Increase COVID Severity

Most COVID cases were mild or moderate in patients treated with ofatumumab

Synesthesia Found 3 Times More Common Among Patients With Multiple Sclerosis - Vimarsana News

Synesthesia Found 3 Times More Common Among Patients With Multiple Sclerosis

Synesthesia is likely to occur at a rate 3-times higher among patients with multiple sclerosis, warranting further research into this relationship.

Arbaclofen Extended-Release Reduces Multiple Sclerosis-Related Spasticity - Vimarsana News

Arbaclofen Extended-Release Reduces Multiple Sclerosis-Related Spasticity

Arbaclofen extended-release tablets twice-daily are safe and effective for the treatment of spasticity in multiple sclerosis.